Showing results (1801-1810 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|August 26, 2026
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapseJ E Bergsma, E M Argiro, K Oosterink, et al.Transplantation and Cellular Therapy|August 12, 2026
A Comprehensive Rehabilitation Framework to help optimize outcomes across the CAR-T Continuum - White Paper ReportJaleel A Mohammed, Zubaida Mohamed, Anne Gonzales, et al.Transplantation and Cellular Therapy|August 15, 2026
CAR-FIT: CAR-T fitness index for therapy - integrating comorbidity and geriatric assessments to guide safe and equitable delivery of CAR-T in patients with borderline physiological reserveKye Ling Wong, Lawrence Cheng Kiat Ng, Nicole-Ann Lim, et al.Transplantation and Cellular Therapy|August 19, 2026
Venetoclax-augmented RIC allogeneic HCT with PTCy-based GVHD prophylaxis and venetoclax/azacitidine maintenance for poor risk MDS and AMLH Moses Murdock, Kyle Hebert, Mahasweta Gooptu, et al.Transplantation and Cellular Therapy|August 18, 2026
Outcomes after Matched Sibling Donor versus Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based GVHD ProphylaxisMuhammad Umair Mushtaq, Amir Kasaeian, Tahereh Rostami, et al.Transplantation and Cellular Therapy|August 18, 2026
Hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: clinical practice guidelines from the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Naveen Pemmaraju, et al.Transplantation and Cellular Therapy|August 19, 2026
Gemtuzumab Ozogamicin-Containing Salvage Strategies as a Bridge to Second Allogeneic Hematopoietic Stem Cell Transplantation in Post-Transplant Relapsed AMLLiu Xiao-Hong, Jing Long, Cao Xing-Yu, et al.Transplantation and Cellular Therapy|September 10, 2026
Early gut microbiome metabolites and diversity predict GVHD-free survival after allogeneic hematopoietic cell transplantationShaweta Kaundal, Amol N Patil, Pankaj Khatri, et al.Transplantation and Cellular Therapy|September 11, 2026
Mutational Landscape and Clonal Dynamics in AML Undergoing PTCy Hematopoietic Cell TransplantationMarta Villalba, José V Gil, Juan Montoro, et al.Transplantation and Cellular Therapy|August 15, 2026
Dengue Fever in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation Recipients: Clinical Characteristics and OutcomesL M Brandão, A C Cortez, J A Balthazar, et al.Pageof 183